Beam Global's CEO Desmond Wheatley is participating in two prominent investment conferences, enhancing the company's visibility among investors. The engagement offers one-on-one meeting opportunities ...

As a result of Joseph Beam and Capital Investment Group’s lack of due diligence, failure to act in the best interest of their customers, and misrepresentations of GWG L Bonds as safe, low-risk ...

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that Eli ...

Charles Schwab Investment Management Inc. boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 3.1% during the 4th quarter, Holdings Channel.com reports. The institutional ...